IL144842A0 - Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant - Google Patents

Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant

Info

Publication number
IL144842A0
IL144842A0 IL14484200A IL14484200A IL144842A0 IL 144842 A0 IL144842 A0 IL 144842A0 IL 14484200 A IL14484200 A IL 14484200A IL 14484200 A IL14484200 A IL 14484200A IL 144842 A0 IL144842 A0 IL 144842A0
Authority
IL
Israel
Prior art keywords
artificial
preparation
surface activity
surfactant
peptides
Prior art date
Application number
IL14484200A
Other languages
English (en)
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of IL144842A0 publication Critical patent/IL144842A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14484200A 1999-02-12 2000-02-09 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant IL144842A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000275A IT1308180B1 (it) 1999-02-12 1999-02-12 Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
PCT/EP2000/001044 WO2000047623A1 (fr) 1999-02-12 2000-02-09 Peptides artificiels ayant une activite de surface et utilisation de ceux-ci dans la preparation d'un tensioactif artificiel

Publications (1)

Publication Number Publication Date
IL144842A0 true IL144842A0 (en) 2002-06-30

Family

ID=11381859

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14484200A IL144842A0 (en) 1999-02-12 2000-02-09 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant

Country Status (33)

Country Link
US (1) US7053044B1 (fr)
EP (1) EP1151008B1 (fr)
JP (1) JP4754073B2 (fr)
KR (1) KR100645145B1 (fr)
CN (1) CN1221570C (fr)
AR (1) AR022578A1 (fr)
AT (1) ATE280181T1 (fr)
AU (1) AU758735B2 (fr)
BG (1) BG65196B1 (fr)
BR (1) BR0009964A (fr)
CA (1) CA2362507C (fr)
CO (1) CO5241361A1 (fr)
CZ (1) CZ301108B6 (fr)
DE (1) DE60015082T2 (fr)
EA (1) EA004058B1 (fr)
EE (1) EE04879B1 (fr)
ES (1) ES2228473T3 (fr)
GE (1) GEP20032976B (fr)
HK (1) HK1042500A1 (fr)
HU (1) HU228997B1 (fr)
IL (1) IL144842A0 (fr)
IT (1) IT1308180B1 (fr)
MA (1) MA25381A1 (fr)
NO (1) NO20013888D0 (fr)
NZ (1) NZ513451A (fr)
PL (1) PL201084B1 (fr)
PT (1) PT1151008E (fr)
SK (1) SK286428B6 (fr)
TR (1) TR200102308T2 (fr)
UA (1) UA72751C2 (fr)
WO (1) WO2000047623A1 (fr)
YU (1) YU57701A (fr)
ZA (1) ZA200106530B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
EP1259222A1 (fr) * 2000-02-11 2002-11-27 ALTANA Pharma AG Nouvelle utilisation d'un surfactant pulmonaire dans la prophylaxie et le traitement des maladies pulmonaires chroniques
EP1752161A3 (fr) * 2002-03-01 2010-09-01 CHIESI FARMACEUTICI S.p.A. Surfactives pulmonaires contenant une polymyxine pour améliorer les propriétés de surface
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
CN100401896C (zh) * 2002-12-09 2008-07-16 儿童医院医疗中心 诊断和治疗间质性肺病的方法
EP1481665A1 (fr) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Nouveaux mélanges lipidiques pour tensioactifs synthétiques
EP1660098A1 (fr) * 2003-08-28 2006-05-31 ALTANA Pharma AG Utilisation de preparations tensioactives dans le traitement d'adherences de type chirurgical
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
CA2658478C (fr) 2006-07-20 2018-02-13 University Of Rochester Tensioactif pulmonaire synthetique et utilisation associee
PL2078038T3 (pl) * 2006-10-13 2014-05-30 Chiesi Farm Spa Rekonstytuowane środki powierzchniowo czynne o ulepszonych właściwościach
EP1997502A1 (fr) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Agents tensioactifs reconstitués dotés de propriétés améliorées
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
EP2022798A1 (fr) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Peptides synthétiques de surfactant pulmonaire
NZ593892A (en) 2008-12-23 2013-11-29 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
BR112012004651B1 (pt) 2009-09-08 2022-02-08 Chiesi Farmaceutici S.P.A. Surfactante pulmonar exógeno, uso de uma combinação terapêutica, medicamento e kit
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2013160129A1 (fr) * 2012-04-23 2013-10-31 Chiesi Farmaceutici S.P.A. Procédé et système pour l'administration d'un surfactant pulmonaire par atomisation
KR102122088B1 (ko) 2012-11-21 2020-06-12 키에시 파르마슈티시 엣스. 피. 에이. 재구성된 폐 계면활성제
EP3106090A1 (fr) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. Système pour une administration efficace, synchronisée avec la respiration, d'un médicament aux poumons
US20180110948A1 (en) 2015-04-22 2018-04-26 Chiesi Farmaceutici S.P.A Method and system for effective breath-synchronized delivery of medicament to the lungs
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
US20180147262A1 (en) 2015-04-30 2018-05-31 University Of Bremen Novel skin medical and cosmetic care product
MA45772A (fr) 2016-07-28 2021-04-28 Chiesi Farm Spa Procédé et système d'administration d'un médicament sous forme d'aérosol
CN109890446B (zh) 2016-10-26 2022-03-22 奇斯药制品公司 用于帮助通过导管向肺给送药剂的装置
JP2020502242A (ja) 2016-12-22 2020-01-23 キエージ・フアルマチエウテイチ・エツセ・ピ・ア 進行性のｂｐｄの処置のための肺サーファクタント及びステロイドを含む処置的組み合わせ物
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
WO2019115771A1 (fr) 2017-12-15 2019-06-20 Pari Pharma Gmbh Système de nébuliseur, système de maintien, combinaison comprenant un système de nébuliseur et un système de maintien, et procédé d'administration d'aérosol
KR20210005614A (ko) 2018-04-23 2021-01-14 키에시 파르마슈티시 엣스. 피. 에이. Bpd의 예방을 위한 폐 계면활성제 및 스테로이드를 포함하는 치료학적 조합물
EP3666316A1 (fr) 2018-12-14 2020-06-17 PARI Pharma GmbH Dispositif d'administration d'aérosol et procédé pour faire fonctionner un dispositif d'administration d'aérosol
EP3666315A1 (fr) 2018-12-14 2020-06-17 PARI Pharma GmbH Dispositif d'administration d'aérosol et procédé de fonctionnement du dispositif d'administration d'aérosol
EP3843105A1 (fr) 2019-12-23 2021-06-30 PARI Pharma GmbH Dispositif de commande pour système nébuliseur d'aérosol
US20230257446A1 (en) 2020-01-28 2023-08-17 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
CN114159546B (zh) * 2021-12-20 2024-06-04 北京双鹤润创科技有限公司 新一代合成肺表面活性物质制剂及其临床应用
EP4411745A1 (fr) 2023-02-01 2024-08-07 Pari Medical Holding GmbH Procédé d'évaluation médicale, nébuliseur d'aérosol et système d'évaluation médicale

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
ES2189825T3 (es) * 1993-12-08 2003-07-16 Mitsubishi Pharma Corp Nuevo peptido sintetico, tensioactivo pulmonar que lo contiene y remedio para el sindrome de malestar respiratorio.
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
CZ20012876A3 (cs) 2002-06-12
ES2228473T3 (es) 2005-04-16
IT1308180B1 (it) 2001-12-07
WO2000047623A1 (fr) 2000-08-17
PL349785A1 (en) 2002-09-09
AU3279300A (en) 2000-08-29
DE60015082T2 (de) 2006-02-09
NO20013888L (no) 2001-08-09
BG65196B1 (bg) 2007-06-29
BG105764A (en) 2002-03-29
AR022578A1 (es) 2002-09-04
JP4754073B2 (ja) 2011-08-24
CZ301108B6 (cs) 2009-11-11
JP2002541062A (ja) 2002-12-03
KR100645145B1 (ko) 2006-11-10
BR0009964A (pt) 2002-04-09
EP1151008A1 (fr) 2001-11-07
ITMI990275A1 (it) 2000-08-12
CO5241361A1 (es) 2003-01-31
HUP0200141A2 (en) 2002-06-29
ATE280181T1 (de) 2004-11-15
EA200100749A1 (ru) 2002-02-28
NO20013888D0 (no) 2001-08-09
US7053044B1 (en) 2006-05-30
CA2362507A1 (fr) 2000-08-17
ZA200106530B (en) 2002-10-14
KR20010101904A (ko) 2001-11-15
DE60015082D1 (de) 2004-11-25
EE04879B1 (et) 2007-08-15
SK286428B6 (sk) 2008-09-05
YU57701A (sh) 2003-07-07
EE200100413A (et) 2002-12-16
CN1221570C (zh) 2005-10-05
NZ513451A (en) 2003-05-30
MA25381A1 (fr) 2002-04-01
HK1042500A1 (en) 2002-08-16
EP1151008B1 (fr) 2004-10-20
AU758735B2 (en) 2003-03-27
UA72751C2 (en) 2005-04-15
GEP20032976B (en) 2003-05-27
TR200102308T2 (tr) 2002-04-22
EA004058B1 (ru) 2003-12-25
HUP0200141A3 (en) 2002-09-30
PL201084B1 (pl) 2009-03-31
CN1340060A (zh) 2002-03-13
CA2362507C (fr) 2012-01-03
HU228997B1 (en) 2013-07-29
PT1151008E (pt) 2005-01-31
SK11442001A3 (sk) 2001-12-03

Similar Documents

Publication Publication Date Title
HK1042500A1 (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
HK1047250A1 (zh) 組織填補物料和方法
IL145715A0 (en) Formulation arrays and use thereof
HUP0203811A3 (en) Use of polymeric material in the treatment of hard surfaces
HUP0000963A3 (en) The use of levobupivacaine in paediatric surgery
HUP0000873A3 (en) The use of levobupivacaine in facial surgery
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
ZA983239B (en) Stable active human ob protein compositions and methods
EP1086215A4 (fr) Preparation et utilisation de vaccins superieurs
EP1308509A4 (fr) Peptide acitf sur le plan physiologique et utilisation de celui-ci
IL131719A0 (en) Iren protein its preparation and use
SI1151008T1 (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
GB2351459B (en) Improvements in and relating to the application of materials
GB9912085D0 (en) Use of amino acids in hair treatment
EP1275659A4 (fr) Nouveaux peptides a activite physiologique et leur utilisation
NZ329917A (en) Peptides having somatostatin antagonistic activity and their use in the enhancement of meat production
IL156077A0 (en) Analogues of thiocoraline and be-22179
HK1044546A1 (zh) Prosaposin衍生反轉肽及其用途
GB9929581D0 (en) Comjpositions and their use
GB9916702D0 (en) Virus vectors and preparations and their use
EP1150685A4 (fr) Tensioactifs a base de phosphocholine et leurs utilisations
HK1047116A1 (zh) 來自mage的免疫原性肽及其應用
HUP0200775A3 (en) Use of pegylated interferon-alpha in melanoma therapy